Literature DB >> 19448451

Cytomegalovirus in the intensive care unit: pathogen or passenger?

Jeffrey I Cohen.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19448451      PMCID： PMC2775818          DOI： 10.1097/CCM.0b013e3181a5e725

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  17 in total

1.  Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.

Authors:  Andre C Kalil; Josh Levitsky; Elizabeth Lyden; Julie Stoner; Alison G Freifeld
Journal:  Ann Intern Med       Date:  2005-12-20       Impact factor: 25.391

2.  Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts.

Authors:  Raymund R Razonable; Cara Fanning; Robert A Brown; Mark J Espy; Antonio Rivero; Jennie Wilson; Walter Kremers; Thomas F Smith; Carlos V Paya
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

3.  High incidence of active cytomegalovirus infection among septic patients.

Authors:  A S Kutza; E Muhl; H Hackstein; H Kirchner; G Bein
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

4.  Cytomegalovirus infection in critically ill patients: associated factors and consequences.

Authors:  Samir Jaber; Gérald Chanques; Jean Borry; Bruno Souche; Régis Verdier; Pierre-François Perrigault; Jean-Jacques Eledjam
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

5.  Cytomegalovirus infection associated with a decreased proliferative capacity and increased rate of apoptosis of peripheral blood lymphocytes.

Authors:  A P van den Berg; L Meyaard; S A Otto; W J van Son; I J Klompmaker; G Mesander; L H de Leij; F Miedema; T H The
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

6.  Human cytomegalovirus infections in nonimmunosuppressed critically ill patients.

Authors:  A Heininger; G Jahn; C Engel ; T Notheisen; K Unertl; K Hamprecht
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

7.  Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery.

Authors:  Y Domart; J L Trouillet; J Y Fagon; J Chastre; F Brun-Vezinet; C Gibert
Journal:  Chest       Date:  1990-01       Impact factor: 9.410

Review 8.  Herpes simplex virus type 1 and respiratory disease in critically-ill patients: Real pathogen or innocent bystander?

Authors:  A M Simoons-Smit; E M Kraan; A Beishuizen; R J Strack van Schijndel; C M Vandenbroucke-Grauls
Journal:  Clin Microbiol Infect       Date:  2006-11       Impact factor: 8.067

9.  Occult herpes family viral infections are endemic in critically ill surgical patients.

Authors:  Charles H Cook; Larry C Martin; Jeffrey K Yenchar; Michael C Lahm; Brian McGuinness; Elizabeth A Davies; Ronald M Ferguson
Journal:  Crit Care Med       Date:  2003-07       Impact factor: 7.598

10.  Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation.

Authors:  F Stéphan; D Méharzi; S Ricci; A Fajac; F Clergue; J F Bernaudin
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440
View more
  3 in total

1.  Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis.

Authors:  Xi Li; Yongbo Huang; Zhiheng Xu; Rong Zhang; Xiaoqing Liu; Yimin Li; Pu Mao
Journal:  BMC Infect Dis       Date:  2018-06-28       Impact factor: 3.090

2.  Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience.

Authors:  Jingtao Cui; Wenjuan Yan; Hongjie Xie; Shaoxia Xu; Qiaofeng Wang; Weihong Zhang; Anping Ni
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

Review 3.  Cytomegalovirus pneumonia: community-acquired pneumonia in immunocompetent hosts.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2010-03       Impact factor: 5.982
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.